1992 In May, Boston Science was successfully listed on the New York Stock Exchange.
1995, acquisition of SCIMEDLifeSystem. In 2004, Boston Scientific Company introduced Taxus into the American market. Express2？ Paclitaxel eluting coronary stent system.
In 2006, Boston Scientific Company revolutionized the acquisition of Kato Company.